LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | JW-7-24-1 | 1.11 | uM | LJP6 | 3 | B21 | 72 | hr | 962 | 8963 | 10641 | 0.8423 | 0.9034 |
MCF 10A | JW-7-24-1 | 3.33 | uM | LJP6 | 1 | B20 | 72 | hr | 962 | 6623 | 10693 | 0.6193 | 0.7424 |
MCF 10A | JW-7-24-1 | 3.33 | uM | LJP6 | 2 | B20 | 72 | hr | 962 | 6878 | 10740 | 0.6404 | 0.7596 |
MCF 10A | JW-7-24-1 | 3.33 | uM | LJP6 | 3 | B20 | 72 | hr | 962 | 7200 | 10641 | 0.6766 | 0.7869 |
MCF 10A | JW-7-24-1 | 10 | uM | LJP6 | 1 | B19 | 72 | hr | 962 | 1510 | 10693 | 0.1412 | 0.1385 |
MCF 10A | JW-7-24-1 | 10 | uM | LJP6 | 2 | B19 | 72 | hr | 962 | 1309 | 10740 | 0.1219 | 0.0925 |
MCF 10A | JW-7-24-1 | 10 | uM | LJP6 | 3 | B19 | 72 | hr | 962 | 1561 | 10641 | 0.1467 | 0.1498 |
MCF 10A | Dasatinib | 0.04 | uM | LJP6 | 1 | I06 | 72 | hr | 962 | 2946 | 10693 | 0.2755 | 0.3800 |
MCF 10A | Dasatinib | 0.04 | uM | LJP6 | 2 | I06 | 72 | hr | 962 | 3062 | 10740 | 0.2851 | 0.3946 |
MCF 10A | Dasatinib | 0.04 | uM | LJP6 | 3 | I06 | 72 | hr | 962 | 2649 | 10641 | 0.2489 | 0.3392 |
MCF 10A | Dasatinib | 0.04 | uM | LJP5 | 1 | D06 | 72 | hr | 962 | 9444 | 10714 | 0.8815 | 0.9287 |
MCF 10A | Dasatinib | 0.04 | uM | LJP5 | 2 | D06 | 72 | hr | 962 | 9020 | 10507 | 0.8584 | 0.9134 |
MCF 10A | Dasatinib | 0.04 | uM | LJP5 | 3 | D06 | 72 | hr | 962 | 8395 | 10315 | 0.8139 | 0.8832 |
MCF 10A | Dasatinib | 0.12 | uM | LJP6 | 1 | I05 | 72 | hr | 962 | 2279 | 10693 | 0.2131 | 0.2817 |
MCF 10A | Dasatinib | 0.12 | uM | LJP6 | 2 | I05 | 72 | hr | 962 | 2329 | 10740 | 0.2168 | 0.2891 |
MCF 10A | Dasatinib | 0.12 | uM | LJP6 | 3 | I05 | 72 | hr | 962 | 2342 | 10641 | 0.2201 | 0.2925 |
MCF 10A | Dasatinib | 0.12 | uM | LJP5 | 1 | D05 | 72 | hr | 962 | 6464 | 10714 | 0.6033 | 0.7295 |
MCF 10A | Dasatinib | 0.12 | uM | LJP5 | 2 | D05 | 72 | hr | 962 | 5799 | 10507 | 0.5519 | 0.6834 |
MCF 10A | Dasatinib | 0.12 | uM | LJP5 | 3 | D05 | 72 | hr | 962 | 6229 | 10315 | 0.6039 | 0.7259 |
MCF 10A | Dasatinib | 0.37 | uM | LJP6 | 1 | I04 | 72 | hr | 962 | 2003 | 10693 | 0.1873 | 0.2350 |
MCF 10A | Dasatinib | 0.37 | uM | LJP6 | 2 | I04 | 72 | hr | 962 | 1986 | 10740 | 0.1849 | 0.2315 |
MCF 10A | Dasatinib | 0.37 | uM | LJP6 | 3 | I04 | 72 | hr | 962 | 2047 | 10641 | 0.1924 | 0.2433 |
MCF 10A | Dasatinib | 0.37 | uM | LJP5 | 1 | D04 | 72 | hr | 962 | 3063 | 10714 | 0.2859 | 0.3952 |
MCF 10A | Dasatinib | 0.37 | uM | LJP5 | 2 | D04 | 72 | hr | 962 | 3155 | 10507 | 0.3003 | 0.4110 |
MCF 10A | Dasatinib | 0.37 | uM | LJP5 | 3 | D04 | 72 | hr | 962 | 3042 | 10315 | 0.2949 | 0.3998 |